Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Sponsor attribution (Alliance Foundation Trials, LLC.) and related headers were removed from the Study Details page, and a General Poster Session entry was deleted.
    Difference
    0.2%
    Check dated 2025-11-11T03:04:27.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Changes appear limited to formatting and visual layout with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:06.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    3%
    Check dated 2025-10-06T05:59:14.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:35.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release for the page's content. The 'Back to Top' element was removed, a minor UI change and not significant.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:27.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T17:00:24.000Z thumbnail image

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.